South and Central America Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type (Allogeneic, Autologous); Product (Consumables, Equipment, Systems and Software); Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology); Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications); End User (Research Institutes, Hospitals, Others) and Country Category : Biotechnology
Market Introduction
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
Market Dynamics
The South and Central America cell therapy market is expected to reach US$ 415.8 million by 2027 from US$ 271.9 million in 2019; it is anticipated to grow at a CAGR of 5.5% during 2019–2027. Factors such as increasing prevalence of chronic diseases, rising adoption of regenerative medicines and increasing number of approvals for cell-based therapies are expected to boost the growth of the cell therapy market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of cell therapy manufacturing, during the forecast period.
COVID-19 pandemic has become the most significant challenge across the South and Central America region. Countries such as Brazil and Argentina have also registered a significant number of positive patients. For instance, in Brazil, the number of cases increased to about 8.82 million, with 216,000 deaths reported as per the world meter till date. With the outbreak of second wave COVID-19, there has been an increasing number of cases in the Latin American countries. Currently, the country is rapidly increasing its clinical programs to fight against the novel corona virus. There has been a rising focus on cell and gene therapies. For instance, Brazilian Association of Hematology, Hemotherapy and Cellular Therapy have constituted a panel of experts to carefully examine and review the use of cellular therapies for the treatment of COVID 19.
Market Scope
The scope of the South and Central America cell therapy market includes therapy type, product, technology, applications, end user and countries. In terms of therapy type, the allogeneic segment accounted for the largest share of the South and Central America cell therapy market in 2019. In terms of product, the consumables segment accounted for the largest share of the South and Central America cell therapy market in 2019. The viral vector technology segment accounted for the largest share of the South and Central America cell therapy market, by technology, in 2019. In terms of applications, the Oncology segment accounted for the largest share of the South and Central America cell therapy market in 2019. In terms of end user, the Research Institutes segment accounted for the largest share of the South and Central America cell therapy market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the South and Central America cell therapy market report are the World Health Organization (WHO), Food and Drug Administration (FDA), Centers of Disease Control and Prevention (CDC), American Cancer Society, and Brazil National Health Surveillance Agency or ANVISA, Brazilian Association of Hematology, Hemotherapy and Cellular Therapy and among others.
Reasons to Buy Report
- It provides understanding of the South and Central America, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America cell therapy market.
- It helps efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the South and Central America cell therapy market.
- It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
SOUTH AND CENTRAL AMERICA CELL THERAPY MARKET SEGMENTATION
By Therapy Type
- Allogeneic
- Autologous
By Product
- Consumables
- Equipment
- Systems and Software
By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-dimensional Technology
By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
By End User
- Research Institutes
- Hospitals
- Others
By Country
- Brazil
- Argentina
Company Profiles
- NuVasive, Inc.
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Cell Therapy Market – By Therapy Type
1.3.2 South and Central America Cell Therapy Market – By Product
1.3.3 South and Central America Cell Therapy Market – By Technology
1.3.4 South and Central America Cell Therapy Market – By Application
1.3.5 South and Central America Cell Therapy Market – By End User
1.3.6 South and Central America Cell Therapy market – By Countries
2. South and Central America Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Cell Therapy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Therapy Market - South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America Cell Therapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in South America Regions
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints
6. Cell Therapy Market – South and Central America Analysis
6.1 South and Central America Cell Therapy Market Revenue Forecast And Analysis
6.2 South and Central America Cell Therapy Market, By Countries - Forecast And Analysis
6.3 Market Positioning of Key Players
7. South and Central America Cell Therapy Market Analysis – By Therapy Type
7.1 Overview
7.2 South and Central America Cell Therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.1.1 Allogeneic: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
7.4 Autologous
7.4.1 Overview
7.4.1.1 Autologous: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
8. South and Central America Cell Therapy Market Analysis – By Product
8.1 Overview
8.2 Cell Therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.1.1 Consumables: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
8.4 Equipment
8.4.1 Overview
8.4.1.1 Equipment: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
8.5 Systems and Software
8.5.1 Overview
8.5.1.1 Systems and Software: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9. South and Central America Cell Therapy Market Analysis – By Technology
9.1 Overview
9.2 South and Central America Cell Therapy Market Share, by Technology, 2019 and 2027, (%)
9.3 Viral vector Technology
9.3.1 Overview
9.3.1.1 Viral vector Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.1.1 Genome Editing Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.1.1 Somatic Cell Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10. South and Central America cell therapy market Analysis – By Application
10.1 Overview
10.2 South and Central America cell therapy market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
11. South and Central America cell therapy market Analysis – By End User
11.1 Overview
11.2 South and Central America cell therapy market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
12. South and Central America Cell Therapy Market Analysis And Forecasts To 2027 – Regional Analysis
12.1 South and Central America: Cell Therapy Market
12.1.1 Overview
12.1.2 South and Central America: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.3 South and Central America: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Million)
12.1.4 South and Central America: Cell Therapy Market, by Product, 2018–2027 (USD Million)
12.1.5 South and Central America: Cell Therapy Market, by Technology 2018–2027 (USD Million)
12.1.6 South and Central America: Cell Therapy Market, by Application 2018–2027 (USD Million)
12.1.7 South and Central America: Cell Therapy Market, by End User, 2018–2027 (USD Million)
12.1.8 South and Central America: Cell Therapy Market, by Country, 2019 & 2027 (%)
12.1.9 Brazil: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.1 Brazil: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.2 Brazil: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Million)
12.1.9.3 Brazil: Cell Therapy Market, by Product, 2018–2027 (USD Million)
12.1.9.4 Brazil: Cell Therapy Market, by Technology 2018–2027 (USD Million)
12.1.9.5 Brazil: Cell Therapy Market, by Application 2018–2027 (USD Million)
12.1.9.6 Brazil: Cell Therapy Market, by End User, 2018–2027 (USD Million)
12.1.10 Argentina: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Argentina: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Argentina: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Million)
12.1.10.3 Argentina: Cell Therapy Market, by Product, 2018–2027 (USD Million)
12.1.10.4 Argentina: Cell Therapy Market, by Technology 2018–2027 (USD Million)
12.1.10.5 Brazil: Cell Therapy Market, by Application 2018–2027 (USD Million)
12.1.10.6 Brazil: Cell Therapy Market, by End User, 2018–2027 (USD Million)
13. Impact of COVID-19 Pandemic on South and Central America Cell Therapy Market
13.1 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1 NuVasive, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Smith & Nephew
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bristol-Myers Squibb Company
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.3.7 SWOT Analysis
14.3.8 Key Developments
14.4 Cells for Cells
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 2. South and Central America Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 3. South and Central America Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. South and Central America Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. South and Central America Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Brazil Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 8. Brazil Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. Brazil Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. Brazil Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Argentina Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Argentina Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 13. Argentina Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 14. Brazil Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Brazil Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Cell Therapy Market
LIST OF FIGURES
Figure 1. Cell Therapy Market Segmentation
Figure 2. South and Central America Cell Therapy Market Segmentation – By Countries
Figure 3. South and Central America Cell Therapy Market Overview
Figure 4. Allogeneic Therapy Type Segment Held Largest Share of South and Central America Cell Therapy Market
Figure 5. Cell Therapy Market - South and Central America PEST Analysis
Figure 6. South and Central America Cell Therapy Market Impact Analysis of Drivers and Restraint
Figure 7. South and Central America Cell Therapy Market – Revenue Forecast And Analysis – 2019- 2027 (US$ Million)
Figure 8. South and Central America Cell Therapy Market – By Countries Forecast and Analysis – 2019- 2027
Figure 9. Market Positioning Of Key Players In South and Central America Cell Therapy Market
Figure 10. South and Central America Cell Therapy Market Revenue Share, by Therapy Type (2019 and 2027)
Figure 11. Allogeneic: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
Figure 12. Autologous: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
Figure 13. Cell Therapy Market Revenue Share, by Product (2019 and 2027)
Figure 14. Consumables: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 15. Equipment: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 16. Systems and Software: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 17. South and Central America Cell Therapy Market Share, by technology, 2019 and 2027 (%)
Figure 18. Viral vector Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 19. Genome Editing Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 20. Somatic Cell Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. South and Central America cell therapy market Revenue Share, by Application (2019 and 2027)
Figure 25. Oncology: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Cardiovascular: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Orthopedic: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Wound Management: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Other Applications: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. South and Central America cell therapy market Share, by End User, 2019 and 2027 (%)
Figure 31. Hospitals South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Research Institutes: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Others: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. South and Central America: Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. South and Central America Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 36. South and Central America: Cell Therapy Market, by Country, 2019 & 2027 (%)
Figure 37. Brazil: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Argentina: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in South and Central America Country Markets
- NuVasive, Inc.
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
- It provides understanding of the South and Central America, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America cell therapy market.
- It helps efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the South and Central America cell therapy market.
- It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.